John R Janes Jr, MD in Alta, WY - Anesthesiology

John R Janes Jr, MD is a Anesthesiology physician based in Alta, Wyoming. John R Janes Jr is licensed to practice in Wyoming (license number 11126A) and his current practice location is 250 Yellow Rose Dr, Alta, Wyoming. He can be reached at his office (for appointments etc.) via phone at (804) 363-9081.

NPI number for John R Janes Jr is 1831187681 and his current mailing address is 250 Yellow Rose Dr, Alta, Wyoming. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831187681.

Contact Information

	John R Janes Jr, MD
	250 Yellow Rose Dr, Alta, WY 83414
	(804) 363-9081
	Not Available

Physician's Profile

Full Name	John R Janes Jr
Gender	Male
Speciality	Anesthesiology
Location	250 Yellow Rose Dr, Alta, Wyoming
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831187681
Provider Enumeration Date: 10/06/2005
Last Update Date: 01/28/2021

Medical Identifiers

Medical identifiers for John R Janes Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831187681	NPI	-	NPPES
5764700	Medicaid	VA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	0101032736 (Virginia)	Secondary
207L00000X	Anesthesiology	11126A (Wyoming)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John R Janes Jr is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John R Janes Jr, MD 250 Yellow Rose Dr, Alta, WY 83414 Ph: (804) 363-9081	John R Janes Jr, MD 250 Yellow Rose Dr, Alta, WY 83414 Ph: (804) 363-9081

News Archive

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.

Pharma-Nutrition conference to highlight latest research on medical nutrition

Pharma-Nutrition, the new international scientific conference organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to discuss the latest research, concepts and practical applications of medical nutrition in patient treatments, disease management and patient outcomes.

Can doctors in small practices catch a break on meaningful use requirements?

The chair of a House subcommittee on health technology has asked the Centers for Medicare and Medicaid Services (CMS) to exempt doctors in small practices or those who are nearing retirement from new health IT requirements.

Scientists pin down structure of neuronal protein clumps associated with ALS

To create treatments for a disease without any, scientists need to study and understand the driving forces behind the faulty biology. Today, researchers at the University of North Carolina School of Medicine announced the first-ever evidence-based description of the neuronal protein clumps thought to be important in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, a fatal neurodegenerative condition.

John R Janes Jr, MD - Anesthesiology in Alta, WY